IPO Issue Details
Issue Price / Price Band₹452 per share (Fixed Price)
Face Value₹2 Per Share
Lot Size33 Shares per Lot
Total Issue Size4,07,66,550 shares (aggregating up to ₹1,841.76 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenMon, 06 May 2024
Subscription CloseWed, 08 May 2024
Anchor AllotmentFri, 03 May 2024
Basis of AllotmentThu, 09 May 2024
Initiation of RefundsFri, 10 May 2024
Credit of Shares to DematFri, 10 May 2024
Listing DateMon, 13 May 2024
UPI Mandate Deadline2024-05-08
Application & Investment Details
Retail — Min (1 Lots)₹14,916 — 33 shares
Retail — Max (13 Lots)₹193,908 (13 Lots)
HNI — Min (14 Lots)₹2,08,824 — 462 shares
EPS (Pre-IPO)₹11.96
EPS (Post-IPO)₹13.48
P/E Ratio (Pre-IPO)37.78x
P/E Ratio (Post-IPO)33.53x
Pre-IPO Promoter Holding22,24,35,091 shares
Post-IPO Promoter Holding23,92,49,250 shares
Fresh Issue Shares1,68,33,818 shares (aggregating up to ₹760.52 Cr)
Offer for Sale Shares2,39,32,732 shares of ₹2 (aggregating up to ₹1,081.24 Cr)
About Indegene Ltd.
Founded in 1998, Indegene Limited provides digital services for the life sciences industry. They assist with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and sales/marketing support.The company's services can be divided into following categoriesEnterprise Commercial SolutionsOmnichannel ActivationEnterprise Medical SolutionsEnterprise Clinical Solutions and consultancy servicesThe subsidiary of the company, DT Associates Limited, provides consulting services under the "DT Consulting" brand. It helps life sciences companies manage their digital transformation efforts to ensure continued success in customer experience.The company received the Platinum Level award at the 2023 Healthy Workplace Conference and Awards, a recognition given by Arogya World India Trust in partnership with the Public Health Foundation of India.As of December 31, 2023, the company had 65 clients actively engaged with its services.As of December 31, 2023, the company employed 5,181 people worldwide. Of these, 4,461 are based in India, 530 work in North America, 105 in Europe, 73 in China, and 12 in other regions.
Objects of the Issue
Indegene Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
Repayment/prepayment of indebtedness of one of the Material Subsidiaries, ILSL Holdings, Inc.;
2
Funding the capital expenditure requirements of the Company and one of the Material Subsidiaries, Indegene, Inc.; and
3
General corporate purposes and inorganic growth.
Shareholding & Lock-in
Pre-IPO Promoter Holding
22,24,35,091 shares
Post-IPO Promoter Holding
23,92,49,250 shares
Lock-in Period (30%)June 8, 2024
Lock-in Period (50%)August 7, 2024